Press and Announcements

Please check back frequently for news, announcements, and events.



urpose Praetego was founded on rigorous science and a desire to offer a clinical meaningful treatment for debilitating diseases of aging. Our technology inhibits a common driver shared by neurodegeneration, diabetic microvascular disease, and aging. Inhibiting this driver at the initial step could radically impact of Alzheimer’s Disease and other neurodegenerative disorders.  Read More >